| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.63 | 0.0003 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |